Pterostilbene vs Fisetin

Head-to-head comparison of Pterostilbene (trans-3,5-Dimethoxy-4'-hydroxystilbene) and Fisetin (3,3',4',7-Tetrahydroxyflavone) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyPterostilbeneFisetin
CategoryAnti-AgingAnti-Aging
Full Nametrans-3,5-Dimethoxy-4'-hydroxystilbene3,3',4',7-Tetrahydroxyflavone
Molecular Weight256.31 Da286.24 Da
Half-Life2-4 hours3-8 hours
Amino AcidsN/AN/A
Typical Dose50-150 mg/day1000-2000 mg/day
RouteOralOral
Purity≥98%≥98%
Studies Count95180
Research StatusClinicalPre-clinical

Pterostilbene Benefits

  • better bioavailability than resveratrol
  • antioxidant/anti-inflammatory
  • supports metabolic health
  • may support cognitive aging

Fisetin Benefits

  • senolytic activity
  • reduces inflammatory signaling
  • supports mitochondrial function
  • may improve healthspan

Pterostilbene Dosing

50-150 mg/day orally|once daily with food|multi-week study periods

Fisetin Dosing

1000-2000 mg/day orally|1-2 days per month in senolytic-style studies|take with a fat-containing meal

Pterostilbene Side Effects

  • GI upset
  • increased LDL in some studies
  • headache

Fisetin Side Effects

  • GI upset
  • headache
  • possible blood-thinner interaction

Research Overview

Pterostilbene

Pterostilbene has supportive preclinical data and smaller human studies across metabolic and oxidative stress endpoints. Its anti-aging potential is plausible, but it is less established than resveratrol or NR.

Fisetin

Preclinical studies show fisetin can selectively target senescent cells and reduce age-related inflammatory markers. Early human research exists, but definitive anti-aging outcomes in humans are still unproven.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Pterostilbene stacks with:

ResveratrolCoQ10Nicotinamide Riboside

Fisetin stacks with:

QuercetinCoQ10Nicotinamide Riboside
polyphenolbioavailabilityantioxidantmetabolicsenolytichealthspan